Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor Cells
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-17
DOI
10.3389/fphar.2019.00749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Turning the gun on cancer: Utilizing lysosomal P-glycoprotein as a new strategy to overcome multi-drug resistance
- (2016) Nicole Seebacher et al. FREE RADICAL BIOLOGY AND MEDICINE
- Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury
- (2016) Xi Qiu et al. MOLECULAR PHARMACEUTICS
- Antibody-drug conjugates as novel anti-cancer chemotherapeutics
- (2015) C. Peters et al. BIOSCIENCE REPORTS
- SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm
- (2015) K. J. Hamblett et al. CANCER RESEARCH
- Antibody-targeted drugs and drug resistance—Challenges and solutions
- (2015) LeeRon Shefet-Carasso et al. DRUG RESISTANCE UPDATES
- Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter
- (2015) Nicole A. Seebacher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis of Improved Lysomotropic Autophagy Inhibitors
- (2015) Tong Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tumor Cells Chronically Treated with a Trastuzumab-Maytansinoid Antibody-Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments
- (2015) F. Loganzo et al. MOLECULAR CANCER THERAPEUTICS
- Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
- (2013) J. Deckert et al. BLOOD
- P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration
- (2013) Tetsuo Yamagishi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gemtuzumab Ozogamicin
- (2013) Donna Przepiorka et al. JOURNAL OF CLINICAL ONCOLOGY
- Absolute measurement of species differences in sodium taurocholate cotransporting polypeptide (NTCP/Ntcp) and its modulation in cultured hepatocytes
- (2013) Xi Qiu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Target-mediated drug disposition model and its approximations for antibody–drug conjugates
- (2013) Leonid Gibiansky et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- LAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis
- (2012) B. Liu et al. SCIENCE
- Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
- (2010) Y. V. Kovtun et al. CANCER RESEARCH
- Evaluation of the therapeutic efficacy of a VEGFR2-blocking antibody using sodium-iodide symporter molecular imaging in a tumor xenograft model
- (2010) Su-Jin Cheong et al. NUCLEAR MEDICINE AND BIOLOGY
- Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
- (2008) Shu-Feng Zhou et al. CURRENT MEDICINAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now